Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. [electronic resource]
Producer: 20000420Description: 1103-15 p. digitalISSN:- 0735-1097
- Abciximab
- Acetates -- therapeutic use
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- therapeutic use
- Anticoagulants -- therapeutic use
- Combined Modality Therapy
- Coronary Disease -- complications
- Drug Monitoring
- Eptifibatide
- Hemorrhage -- chemically induced
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Infusions, Intravenous
- Myocardial Infarction -- etiology
- Patient Selection
- Peptides -- therapeutic use
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Practice Guidelines as Topic
- Recurrence
- Risk Factors
- Tirofiban
- Treatment Outcome
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.